FDA — authorised 21 December 2020
- Application: BLA761172
- Marketing authorisation holder: RIDGEBACK BIOTHERAPEUTICS
- Local brand name: EBANGA
- Indication: POWDER — IV (INFUSION)
- Status: approved
🇺🇸 EBANGA in United States
FDA authorised EBANGA on 21 December 2020
Marketing authorisations
FDA
- Status: approved
EBANGA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is EBANGA approved in United States?
Yes. FDA authorised it on 21 December 2020; FDA has authorised it.
Who is the marketing authorisation holder for EBANGA in United States?
RIDGEBACK BIOTHERAPEUTICS holds the US marketing authorisation.